The granted US patents defend the company’s own 4D respiratory tracking technology, which permits its SPiN Thoracic Navigation System in efficiently tracking a patient’s respiration during navigational procedures. Veran CEO Jason Pesterfield stated that the patented technology (new software) will fundamentally assist lung specialists in targeting solitary pulmonary nodules (SPN’s) and more quickly diagnose patients with lung cancer as compared to several other procedures [more].